Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

AXGN Relative to the S&P 500

AXGN Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Axogen, Inc. (NASD:AXGN) seasonal charts above shows that a Buy Date of August 10 and a Sell Date of November 17 has resulted in a geometric average return of 7.78% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 15 of those periods. This is a good rate of success, but the return underperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 4.16% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. It also provides products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. The firm s products include avance nerve graft, axoguard nerve connector, axoguard nerve protector, avive soft tissue membrane, acroval neurosensory and motor testing system, and axotouch two-point discriminator. The company was founded in 1977 and is headquartered in Alachua, FL.

To download AXGN seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: AXGN